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Abstract
Background Infection from the SARS-CoV-2 virus has
led to the COVID-19 pandemic. Given the large number
of patients affected, healthcare personnel and facility
resources are stretched to the limit; however, the need
for urgent and emergent neurosurgical care continues.
This article describes best practices when performing
neurosurgical procedures on patients with COVID-19
based on multi-institutional experiences.
Methods We assembled neurosurgical practitioners
from 13 different health systems from across the USA,
including those in hot spots, to describe their practices
in managing neurosurgical emergencies within the
COVID-19 environment.
Results Patients presenting with neurosurgical
emergencies should be considered as persons under
investigation (PUI) and thus maximal personal protective
equipment (PPE) should be donned during interaction
and transfer. Intubations and extubations should be
done with only anesthesia staff donning maximal PPE
in a negative pressure environment. Operating room
(OR) staff should enter the room once the air has
been cleared of particulate matter. Certain OR suites
should be designated as covid ORs, thus allowing for
all neurosurgical cases on covid/PUI patients to be
performed in these rooms, which will require a terminal
clean post procedure. Each COVID OR suite should be
attached to an anteroom which is a negative pressure
room with a HEPA filter, thus allowing for donning and
doffing of PPE without risking contamination of clean
areas.
Conclusion Based on a multi-institutional collaborative
effort, we describe best practices when providing
neurosurgical treatment for patients with COVID-19 in
order to optimize clinical care and minimize the exposure
of patients and staff.

Background
The coronavirus

The coronavirus species are a group of enveloped
positive single-stranded RNA viruses belonging to
the genus beta coronavirus.1 Four of these viruses
cause common cold symptoms while two previously known strains of zoonotic origin, severe acute
respiratory syndrome (SARS-CoV) and Middle East

respiratory syndrome coronavirus (MERS-CoV), can
cause fatal respiratory illnesses.1 The SARS-CoV-2
virus, also known as 2019-nCoV, is a new coronavirus species1 that started the COVID-19 pandemic
as a cluster of viral pneumonia in December 2019
in Wuhan, China, and which is currently spreading
across the USA and the rest of the world.1 2

Transmission

There are two main routes of transmission for
respiratory viruses: aerosolization with droplet
transmission and direct contact modes of transmission, with the virus remaining viable for significant
intervals of time between hours and days on most
surfaces.3 Aerosolized transmission4 5 can be either
droplet (SARS-CoV-2) or airborne (SARS), generally
depending on the size of the expelled particle. Larger
particles once expelled into the air tend to settle on
surfaces or to the ground typically within 1 m of the
source.4 The SARS-CoV-2, like other corona viruses,
can be transmitted via droplets within close proximity
during coughing or sneezing, and thus the recommendation for individuals to remain 6 feet apart (www.
cdc.gov/coronavirus/2019-ncov/prevent-getting-
sick/social-distancing.html). The droplets can enter
through the eyes, mouth, or nose of a nearby person.
Person-to-person transmission via direct contact or
contact with contaminated surfaces can also occur
(https://www.cdc.gov/coronavirus/2019-ncov/infection-control/control-recommendations.html). Close
range aerosol transmission5 is most likely during
high-
risk aerosolization procedures such as endotracheal intubation, extubation, suctioning, chest
compressions, and endonasal and transoral procedures. As per the WHO, airborne transmission—
aerosolized particles that travel through the air
over longer distances—has so far not been shown
to be a transmission mode for this novel coronavirus
(https://www.who.int/publications-detail/
advice- o n- t he- u se- o f- m asks- i n- t he- c ommunity-
during- h ome- c are- a nd- i n- h ealthcare- s ettings-
in-the-context-of-the- n ovel-coronavirus-(
2019-ncov)-outbreak).

Covid-19 syndrome

Coronavirus disease 2019 (COVID-19) is a
unique respiratory illness that can cause a range
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of symptoms varying from asymptomatic to respiratory distress
to multiorgan failure with ensuing death. Anosmia may be a
unique early symptom with the COVID-19 syndrome based on
anecdotal reports from around the world. Based on the Chinese
reports, 81% of patients have mild symptoms, while 14% have
moderate symptoms and 5% have critical illness with the need
for mechanical ventilation. Others present with flu-like symptoms and muscle aches, or gastrointestinal symptoms.6 Elderly
people and those with baseline cardiopulmonary disease appear
to be at greatest risk for poor outcomes with COVID-19. At the
time of this report, the US has the most infected documented
cases in the world with a rising death toll.

Current shortage of personal protective equipment for
covid-19

There is a nationwide shortage of personal protective equipment
(PPE), and disruptions in global supply chains are aggravating
this shortage. This protective equipment is needed most significantly by healthcare providers in close, repeated, or continuous
contact with the infected patients. The WHO’s interim guidance
from February 27, 2020 advises a rational and appropriate use of
PPE based on multiple factors such as the location of a patient,
type of personnel involved, and type of procedures being
performed. The document also highlights steps that can be taken
to safely conserve PPE and improve their efficiency (https://apps.
who.int/iris/handle/10665/331215).
Given the novelty of this disease and the current scarcity of
reliable clinical data, it is essential and responsible for us to share
our collective efforts and experiences in our responsibility to our
patient population requiring neurosurgical care while protecting
the healthcare population. The following document is a summary
of lessons learned across multiple regions (13 healthcare systems
and affiliated experts) of the USA in optimizing conditions for
the safety of our patients and neurosurgical providers, and their
support staff (box 1).

Methods

The current document was formulated with a mission of
serving patients requiring surgical intervention while minimizing SARS-
CoV-2 exposure to non-
infected patients and
staff, understanding the significant shortages of personnel,
facility, and PPE resources. We aim to describe a comprehensive
approach to caring for a surgical patient during the COVID-19

Box 1 Principles of minimizing exposure during
neurosurgical care of patients with covid-19

Categorization of emergent and urgent
neurosurgical procedures

While a comprehensive definition of non-elective procedures is
lacking and depends on individual presentations, the following
list includes procedures that are commonly understood as emergent or urgent:
1. Neurosurgical diagnoses
A. Cranial mass-occupying lesions causing acute neurological deterioration
B. Intracerebral hemorrhage presenting with impending
herniation
C. Symptomatic intracranial aneurysms that are not coilable
or present with hematomas causing mass effect
D. Cranial traumatic injuries
E. Spinal cord compressions
F. Myelopathy
G. Spinal traumatic injuries
H. Cauda equina syndrome

General planning

►► Only surgical on-call teams should be present within hospital

settings

►► Demonstrate appropriate donning and doffing techniques
►► Maximal PPE for all PUIs and COVID-positive patients
►► Reuse N95 masks by placing a face mask over the respirator

and store the N95 in a new brown bag

►► Consider designating 3 ORs as COVID ORs and divide each

OR specific to particular surgical type (Neuro-OTO, General-
Trauma, and Cardiothoracic and Vascular)
►► Anteroom needs to be used for donning and doffing as well
as intubating/extubating patients
►► Consider anesthesia team using long extensions to
endotracheal tubes and portable ventilators to prevent need
for circuit disconnection
►► Minimize personnel for intubations and extubations
644

pandemic including a strategy of decreasing elective surgical
volume to create capacity for a surge in COVID-19 patients.
The authors of this manuscript represent 13 different health
systems including centers in hot spots of New York, Pennsylvania, Washington, and Michigan. They have shared their best
practices being used at their centers, leading to a formulation
of the best practices document. The process was conducted by
creating an initial template for the manuscript led by the first
author. This was iteratively revised by all authors. A thorough
search of prior publications led to a very limited reference list.
It was apparent that, while a lot is being rapidly published on
COVID-19, the precise areas of critical interest for neurosurgical practice were severely limited. In light of the lack of data,
we constructed the model where each author populated all the
areas of the manuscript individually. These submissions were
then collated and edited to optimize the subject matter by the
first author and circulated for edits from the larger group to
create a concise repository of best practices.
Given the tremendous challenges posed by the COVID-19
pandemic, there is a lack of data to support each of these recommendations and thus we present the best practices as options to
adapt based on a health system’s resources and goals. We are
presenting a consortium of practices based on pre-print publications, studies of previous viral illnesses, and emerging experience
from major centers during a worldwide pandemic.

It is critical that all planning and preparation for emergent neurosurgical care be performed in conjunction with the institution’s
central coordination committee.7 Isolated planning without
proper communication will lead to confusion and poor compliance. Additionally, this planning should be performed keeping
in mind the institution’s resources and best available scientific
data. Unilateral expectations unsupported by best evidence may
stress an institution’s global response as adherence to extreme
precautionary measures may not necessarily be safer and may
deplete precious resources. It is also important to realize that
new evidence may change practices in the future. The ultimate
goal of general planning is to safeguard the operators and mitigate in-hospital transmission. The current environment demands
creativity, up-
to-
date knowledge of emerging evidence, and
a collaborative atmosphere. Thus, it is possible that multiple
options could be equally safe and effective as long as sound
scientific principles and emerging evidence are adopted.
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Most patients who are in need of emergent/urgent neurosurgical
care may be lacking appropriate COVID-19 risk factor history or
covid testing and thus should be considered as persons under investigation (PUI) or COVID-19 positive.8 Taking this approach allows
for creation of standardized protocols in managing such patients
as well as enhances safety for all involved, given the necessity of
maximal PPE when interacting with PUI/COVID-19 patients.
Coordinated rehearsals of personnel responsibilities and processes
for patients with covid needing neurosurgical care are essential,
given that personnel within the OR suite should not move to clean
areas. It is also ideal to have numerous posters/laminated sheets to
outline the procedures for contacting personnel for PPE, personnel
exposure, terminal clean, and hospital-based infection protection
authority.9

Personnel

Across the USA there is a general trend to cancelling elective
procedures to minimize the number of healthcare providers
at risk of exposure within the hospital environment. Donning
and doffing of maximal PPE should be demonstrated and hand
hygiene during this process should be emphasized. Given the
importance of proper PPE placement in preventing exposure to
the SARS-Cov-2 virus, adherence should be monitored.
Members of the surgical, anesthesia, and neuromonitoring team
should limit their movements within the OR and between rooms
so as to not expose clean areas to SARS-CoV-2 particulate matter.
This will require the placement of a team member outside the
operative suite in case surgical equipment that is not present in the
OR suite is necessary for continuing the operation. Donning and
doffing should take place within the anteroom to prevent exposure
of clean areas to infectious matter from the operating suite.

Operative suite

Given the multitude of OR suites within most hospital settings,
it is ideal to concentrate all COVID and PUI cases within several
COVID designated ORs. Such ORs should ideally be attached to an
anteroom as a mechanism of preventing exposure of clean areas. In
addition, the designated COVID-19 OR suites should be divided
into rooms focusing on three surgical types: (1) neurosurgical,
otolaryngology, and spinal procedures; (2) general surgery, transplant, and trauma; and (3) cardiothoracic and vascular surgery.
Such division will allow for surgical specialty specific equipment to
be housed within the dedicated covid OR, thus preventing movement of equipment from clean areas to covid designated areas and
vice versa. Hybrid ORs deserve special consideration, and cross-
specialty collaboration might be the only way to achieve economies
of scale that allow focusing one or more hybrid ORs for patients
with covid and others for non-COVID patients.
Given the positive pressure areas within the operative suite, it
is essential to have a negative pressure area with HEPA filtration
for doffing, donning, as well as intubation and extubation as both
of these procedures will lead to significant aerosolization. Such
an area is defined as the anteroom which needs to be attached to
each COVID designated operative suite and serves an essential
feature of preventing contamination of adjacent clean areas. Post
procedure, the COVID OR should undergo a terminal clean of
all exposed material from ceiling to floor including lighting.

Intraoperative and periprocedural neurosurgical
care

Direct communication should take place between the transporting team to the OR personnel in the room to be certain
that all individuals have appropriate PPE before transport.

Box 2

Procedure prioritization

A strategy to prioritize invasive procedures that are allowed to
continue under conditions of pandemic surge. Level IIIb cases are
the first to be cancelled or disallowed.
Level I – Delay in surgery >24 hours will result in adverse clinical
outcome (urgent/emergency surgery)
Level II – Prolonged delay in surgery may result in adverse
clinical outcome
Level IIa – System stress: surgery will use limited hospital
resources that are needed for patients with higher levels of
acuity
Level IIb – Patient stress: prolonged delay likely will place
patient at clinical risk
i. Risk of disease progression within 1 month places
patient at risk that is felt to outweigh risk of procedure in
pandemic environment
ii. Risk of disease progression within 3 months places
patient at risk that is felt to outweigh risk of procedure in
pandemic environment
Level III – Prolonged delay in surgery will not result in adverse
clinical outcome (truly elective surgery)
Level IIIa – Elective surgery that does not use significant
system resources
Level IIIb – Elective surgery that does use significant system
resources

Transportation of non-intubated patients should be done with a
face mask in place. Portable ventilators and extensions to endotracheal tubes are important ways to prevent the need for disconnecting the circuit. When a disconnection is necessary, clamping
of the endotracheal tube is essential to prevent aerosolization.
Intubations and extubations are ideally performed within a
negative pressure room and thus the anteroom is a suitable location.10 Only the anesthesia team donning maximal PPE should
be within the room when performing intubation and extubation in order to minimize exposure to other team members.11 12
The surgical team should wait for a period of time post intubation/extubation, ideally corresponding to twice the predicted
time of air turnover in the room, to reduce the aerosolization
content within the COVID OR environment before entering
with maximal PPE including a N95 respirator. Given the rise
in patients with COVID-19 and thus the demand for ICU beds
and ventilators, extubation post procedure should be emphasized thus freeing up a ventilator and ICU room. Post extubation, efforts should be made to transport the patient to a final
destination rather than intermediary locations such as the post
anesthesia care unit. This will minimize the number of areas
and personnel exposed to patients withCOVID-19. However, it
may be more efficient to have the ability to turn an OR suite
into a negative pressure environment where the patient can be
transported for extubation. This will allow the COVID OR suite
to be more efficiently used for surgical procedures rather than
extended periods of time for recovery until extubation. Some
may advocate extubating only outside of the OR, in particular to
perform extubation in the critical care unit; however, this does
not fully incorporate the flow of patients in the hospital, especially in busy centers, and may add a significant number of ventilator days during a time when ventilators are a scarce resource.
Neurosurgical procedures specifically involving the airways
can lead to significant aerosolization and exposure of surgeons
and others within the operative suite. In addition, high-speed
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Box 3 Prioritization of common cerebrovascular
interventions
Level I – Urgent/emergency
Ruptured intracranial aneurysm/arteriovenous malformation/
arteriovenous fistula
Symptomatic intracranial aneurysm (crescendo headache,
cranial neuropathy, visual deterioration, etc)
Acute ischemic stroke thrombectomy
Carotid blowout/bleeding head and neck tumor with airway
compromise
Intracranial hemorrhage or mass with high risk for herniation
Refractory, severe epistaxis
Acute stroke meeting hemicraniectomy criteria
Symptomatic vasospasm
Cortical venous thrombosis with infarct or hemorrhage, high
risk with medical treatment alone
Level II – Risk for adverse clinical outcome
Level IIa – System stress
Any Level IIb(i) procedure expected to require >5 days of ICU
stay and/or >3 days of mechanical ventilation
Level IIb – Patient stress
i. Risk of disease progression within 1 month
Acutely symptomatic carotid stenosis, low risk for
reperfusion injury
Recurrent, severe epistaxis under temporary control
Delayed angiography of atypical, angiogram-negative
subarachnoid hemorrhage
Intervention for idiopathic intracranial hypertension with
vision loss
ii. Risk of disease progression within 3 months
Surveillance angiography for ruptured aneurysm treated
by endovascular occlusion first
Intracranial mass lesion, minimally symptomatic or
asymptomatic
Level III – Limited risk in adverse clinical outcome (truly elective
surgery)
Level IIIa – elective surgery that does not use significant
system resources
Surveillance angiography of unruptured aneurysms or after
1 year for ruptured aneurysm
Level IIIb – elective surgery that does use significant system
resources

bone drilling has been shown to increase production of contaminant aerosolized particulate matter, as reported by Workman
et al,13 and thus participants should be in full PPE. In the same
manner, the use of electrocautery has also been shown to increase
production of contaminated aerosolized particulate matter.14
Thus, neurosurgical operative procedures involving endonasal
approaches for tumor resection and pituitary surgeries as well
as transoral approaches for spinal pathology should be avoided
unless absolutely necessary. Such procedures should be some of
the first cases delayed secondary to the substantial exposure of
healthcare personnel to infectious particulate matter.

Resource utilization if PPE is not available

With the continual rise of COVID-19 cases it is plausible that there
will be scarcity of appropriate PPEs. Specifically, N95 masks are
integral to preventing exposure to COVID-19 particulate matter
and appear to be in short supply. Ideally, N95 masks should be
changed from patient to patient. There are ongoing discussions
646

regarding the reuse or sterilization of used N95 masks. The FDA
has recently approved the use of hydrogen peroxide vapors to
decontaminate N95 masks, as this disinfects without compromising the mechanical integrity of the mask (https://www.fda.gov/
media/
136386/
download). Innovative mechanisms of sterilizing
used N95 respirators have also included heat and ultraviolet light
sources as well as hydrogen peroxide vapors. There is no evidence
to support sterilization with ultraviolet light and heat without the
possibility of reducing the effectiveness of the N95 respirator.
Reuse of N95s may be enhanced by wearing a surgical facemask over the N95, thus preventing its gross contamination. In
addition, a replacement of the N95 mask could be the reusable
elastomeric half-mask respirator (EHMR), which has the same
ability to filter infected particulate matter and allows for a tight
fit over the face. In addition, the face piece can be disinfected
with alcohol or bleach and the cartridges can be replaced to
allow for reuse. Pompeii et al15 recently reported that healthcare personnel can be rapidly fit tested and trained to use the
EHMR. The utilization of other types of masks with the same
functionality as the N95 has been discussed, including the use of
anesthesia face masks attached to HEPA filter and straps. See the
Occupational Safety and Health Administration (OSHA) video
on the application of N95 and EHMRs at https://www.osha.gov/
video/respiratory_protection/resptypes.html.

Improving inpatient capacity by minimizing
scheduled cases

During a heavy influx of patients affected with COVID-19, hospital
bed availability and critical care resources may become severely
limited. A typical approach has been to create capacity by limiting
routine clinical work. However, other clinical needs continue and
cannot be ignored as the delay in management of emergent or
urgent patient care can increase morbidity and mortality. Disrupted
supply chains leading to limited PPEs, medical devices, and critical
care resources and limitations in inpatient capacity make it necessary to identify patients whose care may be delayed without harm
versus those whose health will be compromised by delay in care.

Procedure prioritization

A successful strategy for determining which invasive procedures
should be allowed to proceed must take into consideration the
medical urgency or risk to the patient, the resources required
before, during and after the procedure, and the resources available
within the local health system. One very reasonable approach was
adopted by the TriHealth hospital system in Cincinnati, Ohio (M
Delworth, MD; D Kirkpatrick, MD) and is offered here for consideration. The tiers of care take each of the factors listed previously
into consideration so that lower priority (higher level number)
cases are the first to be cancelled in a ‘bottom up’ approach (box 2).
While this stratification of case priority is clearly logical,
interpretation requires a nuanced understanding of the clinical
conditions being considered. For example, a cerebrovascular or
endovascular specialist may see cases of obviously high urgency,
such as stroke or subarachnoid hemorrhage, and cases clearly
considered elective, such as embolization of a low-grade dural
fistula causing tinnitus. However, many other cases are in the
grey zone—for example, large unruptured aneurysms with significant yearly risk of rupture, carotid endarterectomy or stent for
symptomatic disease, which should be done sooner rather than
later as benefit wanes the longer one waits.
Consideration should also be given to what kind of delay
is reasonable in some situations when it comes to prioritizing
patients on a future schedule on a way back towards normalcy.
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Many disease states may allow for several months of delay
without any evidence of expectation of harm to the patient in
excess of the periprocedural risk in itself.

Clinical and resource criteria

Assignment of cases at priority levels II and III should consider
the risk of progression or recurrence of disease, the likely rate of
that progression, and the potential adverse effect on the patient’s
outcome should progression or recurrence occur. It must also take
into consideration the resources required to perform the procedure
and to manage the patient before and after the procedure. One
condition may have only a moderate concern for progression or
recurrence, but its management may require few critical resources
and only a brief stay in hospital, if any. Another may have a higher
concern for progression or recurrence but require a lengthy stay in
the ICU, possibly on a ventilator, and use of critical resources for
many days. In this scenario, the first procedure may be allowed to
move forward but the second may not. Guidance for appropriate
prioritization of common neurovascular procedures based on these
criteria is given in box 3.

Conclusions

Infection from the SARS-CoV-2 virus has led to the COVID-19
pandemic. Given the large number of patients affected, healthcare
personnel and facility resources are stretched to the limit; however,
the need for urgent and emergent surgical and interventional care
will continue. We describe best practice options when providing
neurosurgical treatment of patients with COVID-19 in order
to optimize clinical care and minimize the exposure of patients
and staff. The described best practices may apply to a variety of
operative and interventional procedures given that the goal of
preventing SARS-CoV-2 exposure is of the utmost importance in
all disciplines.
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